Quantum X Labs (QXL) Financials

Quantum X Labs’ (NASDAQ: QXL) latest statements show a company with improving reported earnings and a stronger balance sheet, but with weak operating performance and continued dependence on financing and investment-related income.

Revenue remains the central concern. Quarterly revenue declined from $15.7 million in Q3 2023 and $10.0 million in Q1 2024 to just $293,000 in Q2 2026. Revenue also fell sequentially from $353,000 in Q1 2026. Although the company reports no cost of revenue, its operating expenses continue to substantially exceed sales.

QXL reported $2.4 million of consolidated net income in Q2 2026, compared with a $605,000 loss in Q1. However, the improvement was largely driven by $3.8 million of interest and investment income. Operating income remained negative at $1.4 million, and operating cash flow was negative $1.1 million.

• Reported profitability improved sharply. Consolidated net income increased from a $605,000 loss in Q1 2026 to $2.4 million in Q2 2026, while Q2 basic EPS was reported at $0.17.
• Debt balances have declined substantially. Total short-term and long-term debt fell to approximately $2.2 million at Q2 2026 from about $8.0 million at Q2 2025 and $3.8 million at Q3 2025.
• Cash liquidity improved during the first half of 2026. Cash and equivalents rose from $1.8 million at Q1 2026 to $2.4 million at Q2, while total current assets increased to $3.5 million.
• Shareholders’ equity strengthened. Total equity increased to $25.8 million at Q2 2026 from $21.7 million at Q1 and $5.8 million at Q3 2025, supported partly by equity issuance and reported earnings.
• Restructuring and impairment charges have moderated. The company recorded substantial restructuring and impairment charges in 2023 through 2025, but Q2 2026 included a $134,000 restructuring charge and no impairment charge in the provided income statement.
• Investment income is an important earnings driver. Q2 2026 included $3.8 million of interest and investment income, helping offset the operating loss. Investors should determine whether this income is recurring before assigning it a sustainable earnings valuation.
• Long-term investments now represent a meaningful asset base. QXL reported $4.4 million of long-term investments at Q2 2026, but the statements do not provide enough detail to assess their liquidity, valuation risk, or expected returns.
• Revenue has deteriorated dramatically. Quarterly revenue fell more than 98% from $15.7 million in Q3 2023 to $293,000 in Q2 2026. The latest sequential decline suggests that a sustained operating recovery has not yet emerged.
• Core operations continue to consume cash. Operating cash flow was negative $1.1 million in Q2 2026 and negative $604,000 in Q1 2026. This follows negative operating cash flow in Q3 and Q4 2025, indicating that reported earnings are not consistently converting into cash.
• Near-term liquidity remains tight. Q2 current liabilities of $4.0 million exceeded current assets of $3.5 million. Cash and restricted cash of approximately $2.5 million also covered only about 61% of current liabilities, leaving the company exposed to refinancing or additional capital-raising needs.

Overall, QXL’s balance sheet is considerably stronger than it was in 2024 and early 2025, particularly because of lower debt and higher equity. Nevertheless, the investment case remains highly dependent on a recovery in revenue and operating cash flow. The Q2 profit was driven primarily by non-operating investment income rather than the company’s core business, while the large goodwill balance of $20.7 million—about two-thirds of total assets—could create impairment risk if expected business performance does not improve.

The supplied figures also include several restated and calculated periods, and some Q2 2026 income statement totals do not reconcile cleanly with the cash flow statement’s consolidated net income figure. Investors should review QXL’s latest filing and footnotes before relying on reported earnings or book value.